Kuldeep Singh Rajput is the CEO and Founder of Biofourmis, a global technology-enabled care delivery company, delivering the right care to the right patients at the right time. Biofourmis leverages its proprietary Biovitals® Platform, and library of biomarkers to predict clinical complications and deliver personalized care for patients at-home, across the care continuum. The company filled with committed, passionate people who care about improving experience, productivity and outcomes for patients, and providers and accelerate R&D and market access for our pharmaceutical partners.
Recognized as a “Forbes 30 Under 30 Asia” listee, a PharmaVoice 100 honoree, and a member of the Milken Institute Young Leaders Circle, Rajput has demonstrated strong leadership experience with building teams, developing talent, and successfully growing and managing strategic partnerships with global pharmaceutical manufacturers, health systems and payers. Biofourmis, which was named in 2020 to Forbes’ “AI 50: America’s Most Promising Artificial Intelligence Companies,” became a health tech unicorn in 2022 with a $1.3 billion valuation. The company has raised a total of $465 million from leading venture capital firms, including General Atlantic, CVS Health, Intel Capital, SoftBank, Sequoia Capital, and MassMutual Ventures.